NRP-154 is a tumorigenic epithelial cell line derived from the preneoplastic dorsal-lateral prostate of rats. These cells are exquisitely sensitive to TGF-β induced apoptosis. In contrast, we find that NRP-154 cells can sustain overexpression of exogenous Bax protein, which is different from non-tumor cells where Bax functions as a ubiquitous stimulator of apoptosis. NRP-154 cells stably overexpressing Bax show increased sensitivity to TGF-β induced apoptosis. The degree of TGF-β induced apoptosis displays high correlation with cleavage of Bax at the amino-terminus. Our data indicate that prostate cancer cells can host high levels of latent Bax which can be activated through post-translational modification.
INTRODUCTION
Adenocarcinoma of the prostate is a leading threat to men's health. Prostate cancer mortality results from metastases to the bone and lymph nodes together with progression from androgen-dependent to androgen independent disease [1] . Numerous factors influence the survival of prostate cancer cells. Transforming growth factor-β1 (TGF-β) is a multifunctional cytokine which regulates cell proliferation, differentiation and apoptosis [2] . Bcl-2 family proteins are critical regulators of apoptosis in a variety of tissues, including prostate cancer cells, which share conserved Bcl-2 homology (BH) domains and comprise mainly three groups of proteins: anti-apoptotic members (e.g. Bcl-2, Bcl-xL), pro-apoptotic members (e.g. Bax, Bak) and regulatory BH3-domain-only members (Hrk, Bad, Bid) (for review [3] ). Latent Bax, a pro-apoptotic molecule, is largely cytosolic or loosely associates with intracellular membranes. In response to apoptotic stimuli, Bax undergoes a conformational change, leading to its integration into the mitochondrial outer membrane or endoplasmic reticulum [4] . The membrane translocalization of Bax triggers a number of changes in cellular homeostasis, including perturbation of intracellular Ca 2+ and mitochondrial dysfunction, followed by downstream activation of caspases. Recent studies have suggested that posttranslational modification of Bax, e.g. calpain-mediated cleavage at its amino terminus, play an important role in the apoptotic-cascade of a number of cell types [5] [6] [7] [8] . Proteolytic cleavage of Bax by calpain leads to the generation of p18-Bax, which could function as a BH3-domain only protein with more potent apoptotic functions [9] .
Research in prostate cancer has been limited by the availability of appropriate cell lines. There are only a few human prostatic cell lines in ATCC (American Type Culture Collection), all of which were derived from metastases. In this study we used an androgen-independent, tumorigenic epithelial cell line (NRP-154) that was derived from the preneoplastic dorsal-lateral prostate of Lobund/Wistar rats, a strain that has an unusually high incidence of cancers of the male reproductive system [10] . NRP-154 cells have luminal cell phenotype and are exquisitely sensitive to TGF-β induced apoptosis, and thus provide a useful model to examine the apoptotic signaling cascade in prostate cancer.
Here we identify a surprising and unique property of NRP-154 cells. In contrast to most other known non-tumor cells where Bax has been described as a consistant stimulator of apoptosis, sustained and stable over-expression of Bax (up to 10 fold over endogenous levels) can be achieved in NRP-154 cells without induction of apoptosis. Such re-sult raises an intriguing possibility that other co-factors may exist in NRP-154 cells to regulate the apoptotic effect of Bax, and could thus be responsible for the tumorigenic growth of prostate tissues. We further show that NRP-154 cells overexpressing latent Bax become more sensitive to TGF-β induced apoptosis. Our data supports the concept of Bax-mediated therapy of prostate cancer, and also provides additional insights into the modulatory function of Bax in apoptosis.
MATERIALS AND METHODS

Subcloning
cDNA encoding the mouse Bax was subcloned into the pCEP4 expression vector (Invitrogen, Carlsbad, CA) between the NheI and NotI restriction sites. The GFP-Bax fusion construct was generated as described previously [11] .
Cell culture and transfection
NRP-154 cells were maintained in D-MEM/F-12 media supplemented with 10 % fetal bovine serum, 2 mM glutamine, 15 mM HEPES buffer and 1 % penicillin-streptomycin (Invitrogen) under subconfluent conditions. pCEP4(Bax) or pCDNA3-(GFP-Bax) were transfected into NRP-154 cells using the Lipofectamine 2000 reagent (Invitrogen). NRP-154 cells overexpressing Bax were selected with hygromycin (250 µg/ml), and individual stable clones were established using limited dilution methods. As controls, NRP-154 cells were transfected with the empty pCEP4 plasmid, subjected to hygromycin selection, and treated in the same way as the pCEP4 (Bax) transfected cells.
TGF-β β β β β treatment
Recombinant human TGF-β1 was obtained from R & D Systems (Minneapolis, MN) and acid-activated TGF-β1 was prepared as instructed. Briefly, lyophilized TGF-β1 was reconstituted with sterile 4 mM HCl containing 1 mg/ml BSA (Fraction V, Sigma, St. Louis, MO) to a final stock concentration of 10 µg/ml, aliquoted and stored at -80 o C. 1.5×10 6 cells were seeded onto T75 flasks and cultured for 24 h to reach 30% -40% confluence. Then TGF-β (10 ng/ml) was added to the cells in D-MEM/F-12 media containing 1% fetal bovine serum and 0.1 µM dexamethasome (Sigma). Apoptosis was measured 48 h later.
Western blotting
For Western blotting analysis, whole cell lysates were prepared with RIPA buffer (150 mM NaCl, 20 mM NaH 2 PO 4 , 50 mM NaF, 2 mM EDTA, 0.1 % SDS, 1 % Deoxycholic Acid, 1 % Triton X-100, pH 7.2) in the presence of a protease inhibitor cocktail (Sigma). Equal amounts of protein (40 µg) were resolved using 10 % sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) (Novex, Invitrogen). Antibodies used include the following, monoclonal anti-Bax 6A7 (1: 1000 dilution, Zymed Laboratories, South San Francisco, CA); polyclonal anti-Bax ∆21 (1: 1000 dilution, Santa Cruz Biotechnology, Santa Cruz, CA); Anti-β-actin (Sigma). Horseradish peroxidase-conjugated secondary antibodies (Pierce Biotechnology, Rockford, IL) were applied and chemiluminescence was detected with ECL Plus (Amersham, Piscataway, NJ). Relative protein expression level was quantitatively analyzed via Hitachi scanning densitometry with Hitachi GeneTools CCD-BIO software (Hitachi Software/Engineering Co., San Jose, CA).
Confocal microscopy imaging
For subcellular localization of transiently expressed GFP-Bax, NRP-154 cells were grown on glass-bottomed ∆TC3 dishes (Bioptechs, Inc., Butler, PA) and visualized with a Zeiss LSM-510 laser scanning microscope using a Plan-Apochromat 63× oil or CApochromat 40× water immersion objective.
TUNEL assay
TdT-mediated dUTP Nick End Labeling (TUNEL) assay was performed using ApopTag Fluorescein In Situ Apoptosis Detection Kit (Intergen Company, Purchase, NY). Briefly, the NRP-154 cell lines were grown on glass-bottomed ∆TC3 dishes and treated with TGF-β as described above. Cells were first washed in equilibration buffer, incubated with TdT enzyme in a humidified chamber at 37 o C for 1 h; cells were then washed and incubated (RT, 30 min) in the dark with fluorescein-conjugated anti-digoxigenin . The washed specimens were counterstained with Propidium Iodide (1 µg/ml) and visualized with Zeiss AxioVision fluorescent microscope.
DNA fragmentation assay
Cells were resuspended in a buffer containing 0.15M NaCl, 0.015 M Na citrate, 10 mM EDTA, 1 % sarkosyl, and 0.09 mg/ml proteinase K (Sigma), and incubated for 2 h at 50 o C. DNA was then precipitated with 100 % ethanol, and dissolved in Tris-EDTA buffer. An aliquot of DNA was subjected to DNase-free RNase (0.5 mg/ml, Sigma) treatment for 20 min at 37 o C, and subjected to electrophoresis on 1.5 % agarose.
Flow cytometry detection of apoptosis
TGF-β treated or untreated cells (3 -5×10 6 ) were collected, washed twice with HBSS buffer (Invitrogen) and stained with LIVE/DEAD Cell Viability Kit (Molecular Probes, Eugene, OR). Cells were simultaneously exposed to cell-permeant, green-fluorescent SYTO 10 and cell-impermeant, red-fluorescent DEAD Red (ethidium homodimer-2) nucleic acid stain for 20 min in the dark and then fixed in freshly prepared 4 % glutaraldehyde and washed as instructed. Stained cells were confirmed with Zeiss AxioVision fluorescent microscope (Carl Zeiss, Inc., Thornwood, NY) and analyzed with Cytomics FC 500 (Beckman Coulter, Fullerton, CA) by Rutgers University NIEHS Analytical Cytometry Core Facility. At least 10 4 events were acquired in list mode and analyzed with Cytomitx RXP acquisition software (Beckman Coulter). All experiments were performed 3 times with S.D. < 5%
RESULTS
Stable overexpression of Bax in NRP-154 cells
When GFP-Bax was transfected into NRP-154 cells, no obvious cell death was observed in green fluorescent labeled cells (Fig. 1A and 1D, control) . In fact, most of the cells expressing GFP-Bax show intact cell morphology, with a diffuse pattern of green fluorescence consistent with cytosolic localization of GFP-Bax. This result is surprising and suggests that NRP-154 cells can sustain overexpression of GFP-Bax, although GFP-Bax has been shown to have potent pro-apoptotic functions in other cell lines [12] . Translocation of GFP-Bax from cytosol into intracellular membranes became apparent after 46 h TGF-β (10 ng/ml) treatment and subsequently apoptotic cell death was ensured (Fig. 1F) . The pattern of GFP-Bax translocation upon TGF-β treatment was very similar to Staurosporin (2 µM) induced apoptosis (Fig. 1B and 1C) . Staurosporin had been previously shown to induce Bax translocation from the cytosol to cellular membranes [12] .
In order to differentiate whether the resistant nature of NRP-154 cells to GFP-Bax is due to the GFP-fusion construct or Bax itself, we transfected cDNA encoding the full-length Bax into NRP-154 cells. Through a series of limited-dilutions under constant selection with hygromycin (a selection marker of the pCEP4 plasmid), we obtained multiple independent clones of NRP-154 cells that exhibited sustained overexpression of Bax. As shown in inactive state. The establishment of separate NRP-154 clones with stable overexpression of Bax enables us to test the apoptotic responses of these cells to TGF-β using general cell population assays. Our previous studies have shown that TGF-β is a potent inducer of apoptosis in NRP-154 cells, causing substantial loss of cell numbers within 2-3 d after treatment [13] . As shown in Fig. 3A , the TUNEL assay revealed apoptotic nature of cell death induced by TGF-β is more apparent in NRP-154 overexpressing Bax. Moreover, internucleosomal DNA fragmentation triggered by TGF-β could be detected in a DNA laddering assay (Fig. 3B) .
The morphological hallmarks of apoptosis including cell shrinkage, changes in intracellular granularity, and condensation of cytoplasm and nucleus have been widely used in the fluorescent activated cell sorter (FACS) assay of apoptosis [14] . Direct assessment of cell death and viability was accomplished using fluorescent probes that stain either live or dead cells (see Methods). As shown in degree of cell death, particularly in clones A and C (Fig.  4B and C) , when compared with control cells subjected to selection with mock pCEP4 transfection (Fig. 4A) . Interestingly, clones D display significantly less apoptosis induced by TGF-β (Fig. 4D) , although their Bax differoverexpression is comparable to those of clones A and C. As expected, NRP-154 cells stably overexpressing Bcl-xL are resistant to TGF-β induced apoptosis (Fig. 4E ) [13] .
Our data therefore indicate that different degrees of sensitivity to TGF-β induced apoptosis in NRP-154 cells are subjected to chronic overexpression of Bax. These ences could reflect the existence of distinct cytosolic mechanisms that counter balance the action of exogenous Bax, or post-translational modifications of Bax may exist in NRP-154 cells that could alter its potency as an apoptotic regulator.
Proteolytic cleavage of Bax during TGF-β β β β β induced apoptosis in NRP-154 cells
Proteolytic cleavage of Bax by calpain has been demonstrated in a variety of cells undergoing apoptosis. Such posttranslational modification of Bax may occur at the amino terminus, and the cleavage product of Bax (p18) is more potent in inducing apoptosis than full length Bax [6] [7] [8] . Using a polyclonal antibody against Bax, we detected various degrees of Bax cleavage in the different NRP-154 clones. Under control condition, intrinsic cleavage of Bax could be detected in certain clones of NRP-154 cells, e.g. clone A and C (Fig. 5A ). Following treatment with TGF-β, the proportion of the 18 kDa cleavage product of Bax increased significantly (Fig. 5B) . Interestingly, a close correlation between the generation of p18-Bax and apoptotic cell death was observed. Clones A and C, which were more sensitive to TGF-β induced apoptosis, showed a higher level of p18-Bax. Clones B and D, which were less sensitive to TGF-β induced apoptosis, displayed less p18-Bax. These results show a close correlation between Bax cleavage and TGF-β induced apoptosis.
DISCUSSION
Manipulating the function of Bax can alter the balance between cell proliferation and apoptosis, and may serve as a powerful therapeutic approach to prostate cancer. It is known that reduced Bax expression is associated with the apoptotic resistant nature of some prostate cancer cells [15] . Bax overexpression has been shown to confer apoptosis in certain androgen-independent prostate cancer cells including PC3 [16] and LNCap [17] cells in which over 10 fold Bax overexpression induced siginificant cell death. Recent studies have shown that posttranslational modifications of Bax occurs in cells that commit to undergo apoptosis, and such modifications may function as an amplification mechanism to enhance the apoptotic effect of Bax and its co-factors. For example, proteolytic cleavage of Bax by calpain results in the generation of p18-Bax and a 32 amino acid amino-terminal polypeptide. The p18-Bax has been shown to have enhanced pro-apoptotic function in a number of tumor cell lines, such as HL-60 [5] , Jurkat T cells [6] and SKOV-3 ovarian cancer cells [7] . It has been proposed that p18-Bax may function as a BH3-domain only protein to modulate apoptosis through its increased affinity for Bcl-xL [9] .
In this study, we report three novel findings. First, tumorigenic NRP-154 prostate cancer cells can sustain high level of Bax overexpression without undergoing apoptosis. Second, NRP-154 cells with sustained overexpression of Bax exhibit increased sensitivity to TGF-β induced apoptosis. Third, TGF-β induced apoptosis of NRP-154 cells show apparent correlation with the 18 kD cleavage product of Bax. Our data suggest that excess Bax in NRP-154 cells resides in a latent form that can be proteolytically activated upon discreet stimuli and engage in pro- β moting the execution of apoptosis. Therefore, NRP-154 could serve as a unique model to study Bax regulation, tumorigenesis and TGF-β induced apoptosis in androgenindependent prostate cancer, which may facilitate future studies on the apoptosis resistance mechanisms of certain cancers.
Increasing evidence indicates that the amino-terminus of Bax plays a cytoprotective role by negatively regulating mitochondrial targeting of Bax, through its interactions with cytoplasmic co-factors such as humanin [18] , 14-3-3 [19] and Ku70 [20] . The fact that NRP-154 cells can sustain up to 10 fold Bax overexpression over the endogenous level raises an intriguing possibility that other intrinsic cofactors may exist in NRP-154 cells. These factors may keep Bax in a latent condition and antagonize its apoptotic activity. Such factors could be responsible for the tumorigenic growth of prostate tissue. A better understanding of the possible existence of such molecules will have impact on prostate cancer therapies.
Extensive studies from other cell lines have demonstrated that Bax cleavage is mediated by calpain, a Ca 2+ -dependent protease with diverse cellular functions. Using DNA microarray assays, we have identified changes in several genes related to the apoptotic signaling pathway. In particular, a specific isoform of calpain, calpain-8, is significantly downregulated in NRP-154 cells with sustained overexpression of Bax. Interestingly, the expression of endogenous caplain inhibitor, calpastatin, is not changed (unpublished result). Thus, it is possible that the altered proteolytic cleavage of Bax may reflect the altered function of caplain, perhaps via its altered Ca 2+ -dependent activation mechanisms. Since alteration in Ca 2+ homeostasis has been shown to induce apoptosis in prostate cancer cells [21] , future studies focusing on the cellular and molecular mechanisms underlying the Ca 2+ -dependent regulation of calpain and the resulting proteolysis of Bax should provide important insights into alternative therapies of prostate cancer.
